Form 8K Imunon Inc For: 23 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Imunon Inc (IMNN)
Imunon Inc stock price live, this page displays NASDAQ IMNN stock exchange data. View the IMNN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Imunon Inc real time stock price chart below.
What Is the Imunon Inc Stock Price Today?
The Imunon Inc stock price today is 7.1200.
What Is the Stock Symbol for Imunon Inc?
The stock symbol for Imunon Inc is ""IMNN.""
What Stock Exchange Does Imunon Inc Trade On?
Imunon Inc is listed and trades on the NASDAQ stock exchange.
Is Imunon Inc a Good Stock to Buy?
Determining whether Imunon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMNN quote. (ISIN: US15117N7012)
What Is the Imunon Inc Stock Price Today?
The Imunon Inc stock price today is 7.1200.
What Is the Stock Symbol for Imunon Inc?
The stock symbol for Imunon Inc is ""IMNN.""
What Stock Exchange Does Imunon Inc Trade On?
Imunon Inc is listed and trades on the NASDAQ stock exchange.
Is Imunon Inc a Good Stock to Buy?
Determining whether Imunon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMNN quote. (ISIN: US15117N7012)
7.1200
-0.4265(-5.65%)
Closed·
After Hours
7.3200+0.3200(+4.57%)
·
Fair Value
An estimate of a Imunon's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.5100
7.6565
52 wk Range
0.3700
8.0775
IMNN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IMNN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Imunon's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.51007.6565
52 wk Range
0.37008.0775
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMNN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Imunon's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
153.7499
Upside
+2,059.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Imunon Inc Company Profile
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company’s lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Imunon Inc Earnings Call Summary for Q1/2025
- Q1 2025 EPS of -$0.28 beat forecast of -$0.3575; stock rose 6% to $0.848 in pre-market trading
- Net loss narrowed to $4.1M from $4.9M YoY; R&D costs decreased while administrative expenses increased
- Phase III OVATION 3 trial for IMMUN-one ovarian cancer treatment progressing; 45 clinical sites planned
- Company seeking partnerships and financing for trials; update on funding expected by end of current quarter
- Cash position at $2.9M; negative free cash flow yield of -154% over last 12 months raises financing concerns
Last Updated: 12/05/2025, 16:48
Read Full TranscriptCompare IMNN to Peers and Sector
Metrics to compare | IMNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −5.8x | −0.5x | |
PEG Ratio | −0.02 | −0.14 | 0.00 | |
Price/Book | 22.4x | −1.6x | 2.6x | |
Price / LTM Sales | - | 239.3x | 3.2x | |
Upside (Analyst Target) | - | 192.3% | 40.5% | |
Fair Value Upside | Unlock | 2.5% | 4.4% | Unlock |
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 153.7499
(+2,059.41% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-4.20 / -0.3575
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Imunon Trade On?
Imunon is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Imunon?
The stock symbol for Imunon is "IMNN."
What Is the Imunon Market Cap?
As of today, Imunon market cap is 9.97M.
What Is Imunon's Earnings Per Share (TTM)?
The Imunon EPS (TTM) is -20.86.
When Is the Next Imunon Earnings Date?
Imunon will release its next earnings report on 12 Aug 2025.
From a Technical Analysis Perspective, Is IMNN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Imunon Stock Split?
Imunon has split 5 times.
How Many Employees Does Imunon Have?
Imunon has 25 employees.
What is the current trading status of Imunon (IMNN)?
As of 25 Jul 2025, Imunon (IMNN) is trading at a price of 7.12, with a previous close of 0.50. The stock has fluctuated within a day range of 6.51 to 7.66, while its 52-week range spans from 0.37 to 8.08.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.